Sangamo Therapeutics
SGMO
#10631
Rank
NZ$54.17 M
Marketcap
NZ$0.13
Share price
0.00%
Change (1 day)
-88.56%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -NZ$0.19 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are NZ$34.55 Million. In 2025 the company made an earning of -NZ$0.2 Billion a decrease over its 2024 earnings that were of -NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.19 Billion-0.84%
2025 -NZ$0.2 Billion9.71%
2024 -NZ$0.18 Billion-17.27%
2023 -NZ$0.22 Billion-40.88%
2022 -NZ$0.36 Billion9.79%
2021 -NZ$0.33 Billion41.52%
2020 -NZ$0.23 Billion23.17%
2019 -NZ$0.19 Billion36.33%
2018 -NZ$0.14 Billion36.89%
2017 -NZ$99.6 Million-22.32%
2016 -NZ$0.13 Billion54.86%
2015 -NZ$82.8 Million75.62%
2014 -NZ$47.15 Million0.13%
2013 -NZ$47.09 Million
2011 -NZ$63.3 Million43.66%
2010 -NZ$44.07 Million28.52%
2009 -NZ$34.29 Million-23.55%
2008 -NZ$44.85 Million2.45%
2007 -NZ$43.78 Million19.5%
2006 -NZ$36.64 Million50.78%
2005 -NZ$24.3 Million75%
2004 -NZ$13.89 Million-33.25%
2003 -NZ$20.8 Million-62.27%
2002 -NZ$55.13 Million102.82%
2001 -NZ$27.18 Million23.21%
2000 -NZ$22.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.90 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.05 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.86 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-NZ$4.47 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$18.95 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$23.24 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.53 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.68 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA